Biotech Negotiates Exit from Kendall Square Lab Building
Generation Bio will exit its Kendall Square headquarters since 2018 following its acquisition by an aggregator of drug royalty rights.
TPG Sells Waltham Campus for $578M
A Waltham life science campus has been sold to a California real estate investor after attracting a Cambridge biomanufacturing tenant under the seller’s repositioning project.
Hot Property: 41 Seyon St.
Cambridge-based Generation Bio will build out a cGMP facility in Waltham after leasing over 100,000 square feet from the developers that acquired the property in December 2020.
Cambridge Biotech Signs $104M Lease in Waltham
Cambridge-based Generation Bio Co. will build out a 104,000-square-foot biomanufacturing facility in Waltham after signing a $104 million lease.
